Tumour targeting and therapy experiments using a chemically-modified human antibody fragment directed against the ED-B domain of fibronectin, a marker of angiogenesis
By: by Lorenzo Tarli
Contributors: Eidgenössische Technische Hochschule Zürich
Published: 2000
Language: eng
Notes: Thesis (doctoral)--Swiss Federal Institute of Technology Zurich, 2000.